126 related articles for article (PubMed ID: 35753820)
1. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract][Full Text] [Related]
2. K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.
Scheffler M; Ihle MA; Hein R; Merkelbach-Bruse S; Scheel AH; Siemanowski J; Brägelmann J; Kron A; Abedpour N; Ueckeroth F; Schüller M; Koleczko S; Michels S; Fassunke J; Pasternack H; Heydt C; Serke M; Fischer R; Schulte W; Gerigk U; Nogova L; Ko YD; Abdulla DSY; Riedel R; Kambartel KO; Lorenz J; Sauerland I; Randerath W; Kaminsky B; Hagmeyer L; Grohé C; Eisert A; Frank R; Gogl L; Schaepers C; Holzem A; Hellmich M; Thomas RK; Peifer M; Sos ML; Büttner R; Wolf J
J Thorac Oncol; 2019 Apr; 14(4):606-616. PubMed ID: 30605727
[TBL] [Abstract][Full Text] [Related]
3. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia.
Lin D; Wang D; Li P; Deng L; Zhang Z; Zhang Y; Zhang M; Zhang N
BMC Med Genomics; 2023 Jan; 16(1):13. PubMed ID: 36703207
[TBL] [Abstract][Full Text] [Related]
5. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
6. Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.
Lin H; Zhang G; Zhang XC; Lian XL; Zhong WZ; Su J; Chen SL; Wu YL
BMC Cancer; 2020 Dec; 20(1):1209. PubMed ID: 33297998
[TBL] [Abstract][Full Text] [Related]
7. Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.
Konstantinidou G; Bey EA; Rabellino A; Schuster K; Maira MS; Gazdar AF; Amici A; Boothman DA; Scaglioni PP
Cancer Res; 2009 Oct; 69(19):7644-52. PubMed ID: 19789349
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population.
Jia M; Zhu M; Zhou F; Wang M; Sun M; Yang Y; Wang X; Wang J; Jin L; Xiang J; Zhang Y; Chang J; Wei Q
Int J Cancer; 2017 Feb; 140(4):807-817. PubMed ID: 27861856
[TBL] [Abstract][Full Text] [Related]
9. Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
Ashktorab H; Mokarram P; Azimi H; Olumi H; Varma S; Nickerson ML; Brim H
Oncotarget; 2017 Jan; 8(5):7852-7866. PubMed ID: 28002797
[TBL] [Abstract][Full Text] [Related]
10. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing.
Singh V; Katiyar A; Malik P; Kumar S; Mohan A; Singh H; Jain D
Cancer Biomark; 2023 Sep; ():. PubMed ID: 37694353
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach.
Balasundaram A; C Doss GP
ACS Omega; 2024 Apr; 9(14):16288-16302. PubMed ID: 38617633
[TBL] [Abstract][Full Text] [Related]
13. Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene.
Chen K; Shang Z; Dai AL; Dai PL
Life Sci; 2020 Aug; 255():117816. PubMed ID: 32454155
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets.
Veldore VH; Patil S; Satheesh CT; Shashidhara HP; Tejaswi R; Prabhudesai SA; Krishnamoorthy N; Hazarika D; Naik R; Rao RM; Ajai Kumar BS
Indian J Cancer; 2015; 52(2):243-8. PubMed ID: 26853422
[TBL] [Abstract][Full Text] [Related]
15. The genomic landscape of nonsmall cell lung carcinoma in never smokers.
Boeckx B; Shahi RB; Smeets D; De Brakeleer S; Decoster L; Van Brussel T; Galdermans D; Vercauter P; Decoster L; Alexander P; Berchem G; Ocak S; Vuylsteke P; Deschepper K; Lambrechts M; Cappoen N; Teugels E; Lambrechts D; De Greve J
Int J Cancer; 2020 Jun; 146(11):3207-3218. PubMed ID: 31745979
[TBL] [Abstract][Full Text] [Related]
16. Exome-wide search and functional annotation of genes associated in patients with severe tick-borne encephalitis in a Russian population.
Ignatieva EV; Yurchenko AA; Voevoda MI; Yudin NS
BMC Med Genomics; 2019 May; 12(Suppl 3):61. PubMed ID: 31122248
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
19. The identification of novel gene mutations for degenerative lumbar spinal stenosis using whole-exome sequencing in a Chinese cohort.
Jiang X; Chen D
BMC Med Genomics; 2021 May; 14(1):134. PubMed ID: 34020649
[TBL] [Abstract][Full Text] [Related]
20. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
